Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fabbri

Showing results (41-50 of 570) with videos related to

Pageof 57
Sort By:
American Journal of Respiratory and Critical Care Medicine|March 26, 2010
Genetics, ethics, and the use of long-acting beta-adrenergics to treat asthmaFernando D Martinez, Leonardo M Fabbri
Lancet (London, England)|September 4, 2007
From COPD to chronic systemic inflammatory syndrome?Leonardo M Fabbri, Klaus F Rabe
Respiratory Research|November 2, 2010
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agentsDonald P Tashkin, Leonardo M Fabbri
La Clinica Terapeutica|March 15, 1982
[Therapeutic action of oxolamine in acute tracheo-bronchitis]G Gunella, M Fabbri, M Laghi
American Journal of Respiratory and Critical Care Medicine|October 19, 2017
We Have to Learn to Do without Knowing Enough: Antieosinophilic Treatments for Severe AsthmaAlberto Papi, Bianca Beghé, Leonardo M Fabbri
Internal and Emergency Medicine|November 23, 2021
Urgent need of novel biomarkers of acute dyspneaBianca Beghé, Enrico Clini, Leonardo M Fabbri
Clinics in Chest Medicine|August 18, 2020
Prevention of Chronic Obstructive Pulmonary DiseaseAlberto Papi, Luca Morandi, Leonardo M Fabbri
The Lancet. Respiratory Medicine|March 27, 2015
Eosinophilia in asthma: the easy way is not always the bestBianca Beghè, Antonio Spanevello, Leonardo M Fabbri
Biomaterials|May 1, 1994
Granulates based on calcium phosphate with controlled morphology and porosity for medical applications: physico-chemical parameters and production techniqueM Fabbri, G C Celotti, A Ravaglioli
The European Respiratory Journal|November 28, 2012
Long-term macrolide treatment for chronic respiratory diseasePaolo Spagnolo, Leonardo M Fabbri, Andrew Bush
Pageof 57

Showing results (41-50 of 570) with videos related to

Sort By:
Pageof 57
American Journal of Respiratory and Critical Care Medicine|March 26, 2010
Genetics, ethics, and the use of long-acting beta-adrenergics to treat asthmaFernando D Martinez, Leonardo M Fabbri
Lancet (London, England)|September 4, 2007
From COPD to chronic systemic inflammatory syndrome?Leonardo M Fabbri, Klaus F Rabe
Respiratory Research|November 2, 2010
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agentsDonald P Tashkin, Leonardo M Fabbri
La Clinica Terapeutica|March 15, 1982
[Therapeutic action of oxolamine in acute tracheo-bronchitis]G Gunella, M Fabbri, M Laghi
American Journal of Respiratory and Critical Care Medicine|October 19, 2017
We Have to Learn to Do without Knowing Enough: Antieosinophilic Treatments for Severe AsthmaAlberto Papi, Bianca Beghé, Leonardo M Fabbri
Internal and Emergency Medicine|November 23, 2021
Urgent need of novel biomarkers of acute dyspneaBianca Beghé, Enrico Clini, Leonardo M Fabbri
Clinics in Chest Medicine|August 18, 2020
Prevention of Chronic Obstructive Pulmonary DiseaseAlberto Papi, Luca Morandi, Leonardo M Fabbri
The Lancet. Respiratory Medicine|March 27, 2015
Eosinophilia in asthma: the easy way is not always the bestBianca Beghè, Antonio Spanevello, Leonardo M Fabbri
Biomaterials|May 1, 1994
Granulates based on calcium phosphate with controlled morphology and porosity for medical applications: physico-chemical parameters and production techniqueM Fabbri, G C Celotti, A Ravaglioli
The European Respiratory Journal|November 28, 2012
Long-term macrolide treatment for chronic respiratory diseasePaolo Spagnolo, Leonardo M Fabbri, Andrew Bush
Pageof 57